| Primary |
| Schizophrenia |
26.9% |
| Drug Use For Unknown Indication |
15.1% |
| Product Used For Unknown Indication |
11.3% |
| Psychotic Disorder |
9.5% |
| Schizophrenia, Paranoid Type |
8.8% |
| Hypertension |
5.1% |
| Schizoaffective Disorder |
3.0% |
| Agitation |
2.7% |
| Bipolar I Disorder |
2.5% |
| Hyperlipidaemia |
2.4% |
| Bipolar Disorder |
1.9% |
| Diabetes Mellitus |
1.9% |
| Anxiety |
1.7% |
| Delusional Disorder, Unspecified Type |
1.7% |
| Tic |
1.4% |
| Schizophrenia, Disorganised Type |
1.2% |
| Hiv Infection |
0.8% |
| Schizophrenia, Catatonic Type |
0.8% |
| Prophylaxis |
0.7% |
| Tourette's Disorder |
0.7% |
|
| Weight Increased |
62.8% |
| Tachycardia |
5.6% |
| Toxicity To Various Agents |
2.8% |
| Parkinsonism |
2.3% |
| Pulmonary Embolism |
2.3% |
| Tardive Dyskinesia |
2.3% |
| Treatment Noncompliance |
2.3% |
| Weight Decreased |
2.3% |
| Psychotic Disorder |
1.9% |
| Tremor |
1.9% |
| Akathisia |
1.4% |
| Drug Administration Error |
1.4% |
| Mental Disorder |
1.4% |
| Neuroleptic Malignant Syndrome |
1.4% |
| Rhabdomyolysis |
1.4% |
| Schizophrenia |
1.4% |
| Suicide Attempt |
1.4% |
| Ventricular Tachycardia |
1.4% |
| Vomiting |
1.4% |
| Cognitive Disorder |
0.9% |
|
| Secondary |
| Schizophrenia |
20.0% |
| Drug Use For Unknown Indication |
18.5% |
| Product Used For Unknown Indication |
17.3% |
| Schizophrenia, Paranoid Type |
6.5% |
| Psychotic Disorder |
5.5% |
| Bipolar I Disorder |
5.0% |
| Schizoaffective Disorder |
4.1% |
| Hypertension |
3.8% |
| Agitation |
3.1% |
| Aggression |
1.9% |
| Bipolar Disorder |
1.9% |
| Anxiety |
1.7% |
| Confusional State |
1.4% |
| Depression |
1.4% |
| Enzyme Induction |
1.4% |
| Panic Disorder |
1.4% |
| Prophylaxis |
1.4% |
| Diabetes Mellitus |
1.2% |
| Schizophrenia, Catatonic Type |
1.2% |
| Learning Disorder |
1.0% |
|
| Tachycardia |
18.2% |
| Hyperprolactinaemia |
11.4% |
| Weight Increased |
9.1% |
| Eyelid Ptosis |
6.8% |
| Neuroleptic Malignant Syndrome |
6.8% |
| Schizophrenia, Paranoid Type |
5.7% |
| Hypotension |
4.5% |
| Incorrect Dose Administered |
4.5% |
| Pulmonary Embolism |
3.4% |
| Septic Shock |
3.4% |
| Tremor |
3.4% |
| Urinary Retention |
3.4% |
| Ventricular Tachycardia |
3.4% |
| Completed Suicide |
2.3% |
| Diarrhoea Haemorrhagic |
2.3% |
| Embolism Arterial |
2.3% |
| Gastric Cancer |
2.3% |
| Injection Site Abscess |
2.3% |
| Injection Site Pain |
2.3% |
| Medication Error |
2.3% |
|
| Concomitant |
| Drug Use For Unknown Indication |
27.4% |
| Schizophrenia |
17.0% |
| Schizoaffective Disorder |
5.9% |
| Hypertension |
5.6% |
| Psychotic Disorder |
5.2% |
| Bipolar I Disorder |
4.2% |
| Schizophrenia, Paranoid Type |
3.8% |
| Bipolar Disorder |
3.5% |
| Non-hodgkin's Lymphoma |
3.5% |
| Delusion |
3.1% |
| Depression |
3.1% |
| Product Used For Unknown Indication |
3.1% |
| Breast Cancer Metastatic |
2.8% |
| Insomnia |
2.1% |
| Pain |
2.1% |
| Drug Therapy |
1.7% |
| Schizoaffective Disorder Bipolar Type |
1.7% |
| Dementia Alzheimer's Type |
1.4% |
| Parkinsonism |
1.4% |
| Rheumatoid Arthritis |
1.4% |
|
| Death |
10.0% |
| Wrong Technique In Drug Usage Process |
8.6% |
| Basedow's Disease |
7.1% |
| Macular Oedema |
5.7% |
| Overdose |
5.7% |
| Type 2 Diabetes Mellitus |
5.7% |
| Unresponsive To Stimuli |
5.7% |
| White Blood Cell Count Decreased |
5.7% |
| Pulmonary Embolism |
4.3% |
| Restlessness |
4.3% |
| Schizoaffective Disorder |
4.3% |
| Sedation |
4.3% |
| Suicide Attempt |
4.3% |
| Treatment Noncompliance |
4.3% |
| Weight Increased |
4.3% |
| White Blood Cell Count Increased |
4.3% |
| Akathisia |
2.9% |
| Asthenia |
2.9% |
| Camptocormia |
2.9% |
| Completed Suicide |
2.9% |
|
